Aphria Inc. has agreed to pay $30 million to settle a class-action lawsuit by shareholders alleging the company made ...

In a challenging market environment, Tilray Inc (NASDAQ:TLRY) stock has reached a 52-week low, dipping to $0.94. The cannabis company, which has been navigating through regulatory hurdles and intense ...

The settlement could finally close the chapter on a five-year-old lawsuit alleging Tilray insiders secretly profited from ...

NEW YORK – Tilray Brands, Inc. (NASDAQ:TLRY), a company specializing in medicinal chemicals and botanical products currently trading near its 52-week low, has reached a settlement agreement regarding ...

Tilray Brands settled a multi-year securities class action brought against its subsidiary Aphria and some of its former executives.

Tilray Brands, Inc. (“Tilray” or “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries, today ...

Tilray cultivates and sells cannabis in Canada and exports into the global medical market. It also sells CBD and alcohol. The company is the result of legacy Aphria acquiring legacy Tilray in a ...

Global Leader in Medical Cannabis Launches New Cannabis Extract Products and FormulationsNEUMÜNSTER, Germany, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Tilray Medical ("Tilray"), a division of Tilray Brands, ...

Brands announced the completion of Phase I of its accelerated growth plan for its cannabis supply chain, which began with ...